18-Month efficacy and safety analysis of monthly subcutaneous buprenorphine injection for opioid use disorder: Integrated analysis of phase 3 studies.
Autor: | Rutrick, Daniel1 (AUTHOR), Learned, Susan M.1,2 (AUTHOR), Boyett, Brent3 (AUTHOR), Hassman, David4 (AUTHOR), Shinde, Sunita2 (AUTHOR), Zhao, Yue1,2 (AUTHOR) yue.zhao@indivior.com |
---|---|
Zdroj: | Journal of Substance Use & Addiction Treatment. Nov2023, Vol. 154, pN.PAG-N.PAG. 1p. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |